About This Test
Ki-67 is a nuclear protein playing a pivotal role in maintaining cell proliferation. Ki-67 is present in all non-G0 phases of the cell cycle. Beginning in the mid-G1, the level increases through S and G2 to reach a peak in M phase. In the end of M phase, it is rapidly catabolized. Ki-67 has been employed as a marker of proliferation and hence, prognosis in neoplasms of many types such as Malignant lymphomas, prostatic and breast Adenocarcinomas, Astrocytic neoplasms and Soft tissue neoplasms. Ki-67 is an established prognostic biomarker in breast cancer. It is widely used as a marker of proliferation.
Test Parameters (1)
- IMMUNOHISTOCHEMISTRY, Ki67
Home Collection
✓ Available
Reports Available In
7 Days
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
Provide a copy of the Histopathology report.
Ki-67 is a protein expressed in the nucleus of actively dividing cells. IHC testing for Ki-67 measures the proliferation rate of tumor cells, providing key information about tumor aggressiveness and prognosis.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
